References
- Levine M N, Hirsh J. Sample size in the planning and interpretation of clinical trials. Thromb Haemost 1987; 58: 953–956
- Spiegelhalter D J, Freedman L S. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med 1986; 5: 1–13
- Naylor C D, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?. Ann Intern Med 1992; 117: 916–921
- Forrow L., Taylor W C, Arnold R M. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med 1992; 92: 121–124
- Feinstein A R. Invidious comparisons and unmet clinical challenges. Am J Med 1992; 92: 117–120
- Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981; 211: 453–458
- Warner E, Weinroth J, Chang M, MacDonald M, Strauss B. Phase II trial of Virulizin in patients with pancreatic cancer. Clin Invest Med 1994; 17: 37–41
- Laupacis A, Sackett D L, Roberts R S. Therapeutic priorities of Canadian internists. Can Med Assoc J 1990; 142: 329–333
- Casscells W, Schoenberger A, Graboys T B. Interpretation by physicians of clinical laboratory results. N Engl J Med 1979; 299: 999–1001
- Berwick D M, Fineberg H V, Weinstein M C. When doctors meet numbers. Am J Med 1981; 71: 991–998
- Tversky A, Kahneman D. Judgement underuncertainty: heuristics and biases. Science 1974; 185: 1124–1131
- Laupacis A, Naylor C D, Sackett D L. How should the results of clinical trials by presented to clinicians?. ACP J Club 1992; 116(Suppl 3)A–12–14
- Donner A. Approaches to sample size estimation in the design of clinical trials-a review. Stat Med 1984; 3: 199–214
- Gore S M. Assessing clinical trials—trial size. BMJ 1981; 282: 1687–1689
- McNeil B J, Pauker S G, Sox H C, Jr., et al. On the elicitation of preferences for alternative therapies. N Engl J Med 1982; 306: 1259–1262